Literature DB >> 9582329

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney.

T H van Kuppevelt1, M A Dennissen, W J van Venrooij, R M Hoet, J H Veerkamp.   

Abstract

Detailed analysis of various heparan sulfate (HS) species is seriously hampered by a lack of appropriate tools, such as antibodies. We adopted phage display technology to generate anti-HS antibodies. A "single pot" semisynthetic human antibody phage display library was subjected to four rounds of selection on HS from bovine kidney using panning methodology. Three different phage clones expressing anti-HS single chain variable fragment antibodies (HS4C3, HS4D10, and HS3G8) were isolated, with an amino acid sequence of the complementarity-determining region 3 of GRRLKD (VH3 gene, DP-38), SLRMNGCGAHQ (VH3 gene, DP-42), and YYHYKVN (VH1 gene, DP-8), respectively. The antibodies react with HS and heparin, but not with DNA or other glycosaminoglycans. Kd values for HS are about 0.1 microM. The three antibodies react differently toward various HS preparations and show different staining patterns on rat kidney sections, indicating recognition of different HS molecules. This also holds for two described mouse anti-HS IgMs (JM403 and 10E4; both generated by conventional hybridoma technique) and indicates the presence of at least 5 different HS species in the kidney. O- and N-sulfation are important for binding of HS to HS4C3 and HS3G8. The three single chain antibodies, but not JM403, block a basic fibroblast growth factor binding site of HS. It is concluded that phage display technology presents a powerful technique to generate antibodies specific for HS epitopes. This is the first time this technique has been successfully applied to obtain directly antibodies to (poly)saccharides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582329     DOI: 10.1074/jbc.273.21.12960

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Preparation of single chain variable fragment of MG(7) mAb by phage display technology.

Authors:  Z C Yu; J Ding; Y Z Nie; D M Fan; X Y Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 3.  Heparan sulfate: growth control with a restricted sequence menu.

Authors:  J T Gallagher
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Hitting the sweet spot.

Authors:  Gauri Kulkarni; William G Wadsworth
Journal:  Nat Methods       Date:  2012-04-27       Impact factor: 28.547

Review 5.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

Review 6.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

7.  SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Arie Oosterhof; Toin H van Kuppevelt; Nicole C Smits; Stephen J Kennel
Journal:  Nucl Med Biol       Date:  2011-09-29       Impact factor: 2.408

8.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

9.  Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding.

Authors:  Gerdy B ten Dam; Els M A van de Westerlo; Anurag Purushothaman; Radu V Stan; Johan Bulten; Fred C G J Sweep; Leon F Massuger; Kazuyuki Sugahara; Toin H van Kuppevelt
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

10.  A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.

Authors:  Catherine Whittall; Oksana Kehoe; Sophie King; Antal Rot; Angela Patterson; Jim Middleton
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.